The Carlyle Group Rs37 billion acquisition of 20% stake in Piramal Pharma

27/6/2020
Public acquisition

Re 37 billion

$ 496.265 million

Announced

27/6/2020


Overview:

  • Multinational private equity firm The Carlyle Group has acquired a 20% stake in pharmaceuticals company Piramal Pharma for Rs37 billion.

Shah Shameer Ahmed - Researcher 

Jurisdiction:

India

Deal type:

Public acquisition

Practice area:

M&A

Industry sector:

Pharmaceuticals and life sciences


Firms:

Party: The Carlyle Group (Acquirer)

Lawyer: Sayak Maity


Party: Piramal Group (Seller)